Anatomical phenotyping in a mouse model of fragile X syndrome with magnetic resonance imaging

NeuroImage

Volumn 53, Issue 3, 2010, Pages 1023-1029

  Ellegood, Jacob ^a   Pacey, Laura K ^b   Hampson, David R ^b   Lerch, Jason P ^a   Henkelman, R Mark ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Deep cerebellar nuclei; Fragile X syndrome; Immunohistochemistry; Magnetic resonance imaging

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FASTIGIAL NUCLEUS; FRAGILE X SYNDROME; GENETIC ASSOCIATION; IMMUNOHISTOCHEMISTRY; INTERPOSITUS NUCLEUS; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ANIMALS; CEREBELLAR NUCLEI; DISEASE MODELS, ANIMAL; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956211293     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.03.038     Document Type: Article

References (46)

1. Barnea-Goraly N., Eliez S., Hedeus M., Menon V., White C.D., Moseley M., Reiss A.L. White matter tract alterations in fragile X syndrome: preliminary evidence from diffusion tensor imaging. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 118B:81-88.
2. Bock N.A., Nieman B.J., Bishop J.B., Mark Henkelman R. In vivo multiple-mouse MRI at 7 Tesla. Magn. Reson. Med. 2005, 54:1311-1316.
3. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
4. Courchesne E., Yeung-Courchesne R., Press G.A., Hesselink J.R., Jernigan T.L. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N. Engl. J. Med. 1988, 318:1349-1354.
5. Crawford D.C., Acuna J.M., Sherman S.L. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet. Med. 2001, 3:359-371.
6. Curia G., Papouin T., Seguela P., Avoli M. Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb. Cortex 2009, 19:1515-1520.
7. Dobkin C., Rabe A., Dumas R., El Idrissi A., Haubenstock H., Brown W.T. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 2000, 100:423-429.
8. Dorr A.E., Lerch J.P., Spring S., Kabani N., Henkelman R.M. High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl/6J mice. Neuroimage 2008, 42:60-69.
9. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 1994, 78:23-33. Dutch-Belgium Fragile X Consortium.
10. Freeman J.H., Nicholson D.A. Developmental changes in eye-blink conditioning and neuronal activity in the cerebellar interpositus nucleus. J. Neurosci. 2000, 20:813-819.
11. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
12. Gothelf D., Furfaro J.A., Hoeft F., Eckert M.A., Hall S.S., O'Hara R., Erba H.W., Ringel J., Hayashi K.M., Patnaik S., Golianu B., Kraemer H.C., Thompson P.M., Piven J., Reiss A.L. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann. Neurol. 2008, 63:40-51.
13. Grossman A.W., Elisseou N.M., McKinney B.C., Greenough W.T. Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res. 2006, 1084:158-164.
14. Gruss M., Braun K. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. Neural Plast. 2001, 8:285-298.
15. Gruss M., Braun K. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem. Int. 2004, 45:81-88.
16. Haas B.W., Barnea-Goraly N., Lightbody A.A., Patnaik S.S., Hoeft F., Hazlett H., Piven J., Reiss A.L. Early white-matter abnormalities of the ventral frontostriatal pathway in fragile X syndrome. Dev. Med. Child Neurol. 2009, 51:593-599.
17. Henkelman R.M., Baghdadi L., Sled J.G. Presentation of 3D isotropic imaging data for optimal viewing. Magn. Reson. Med. 2006, 56:1371-1374.
18. Hessl D., Rivera S.M., Reiss A.L. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:17-24.
19. Irwin S.A., Galvez R., Greenough W.T. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex 2000, 10:1038-1044.
20. Jacobs S., Doering L.C. Astrocytes correct abnormal neuronal development in the Fragile X mouse model. Neuroscience 2009, Chicago.
21. Koekkoek S.K., Yamaguchi K., Milojkovic B.A., Dortland B.R., Ruigrok T.J., Maex R., De Graaf W., Smit A.E., VanderWerf F., Bakker C.E., Willemsen R., Ikeda T., Kakizawa S., Onodera K., Nelson D.L., Mientjes E., Joosten M., De Schutter E., Oostra B.A., Ito M., De Zeeuw C.I. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron 2005, 47:339-352.
22. Kooy R.F., Reyniers E., Verhoye M., Sijbers J., Bakker C.E., Oostra B.A., Willems P.J., Van Der Linden A. Neuroanatomy of the fragile X knockout mouse brain studied using in vivo high resolution magnetic resonance imaging. Eur. J. Hum. Genet. 1999, 7:526-532.
23. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001, 13:534-546.
24. Lerch J.P., Carroll J.B., Spring S., Bertram L.N., Schwab C., Hayden M.R., Henkelman R.M. Automated deformation analysis in the YAC128 Huntington disease mouse model. Neuroimage 2008, 39:32-39.
25. Mostofsky S.H., Mazzocco M.M., Aakalu G., Warsofsky I.S., Denckla M.B., Reiss A.L. Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance. Neurology 1998, 50:121-130.
26. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., Ferri R., Oostra B.A. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 2000, 41:19-23.
27. Nieman B.J., Flenniken A.M., Adamson S.L., Henkelman R.M., Sled J.G. Anatomical phenotyping in the brain and skull of a mutant mouse by magnetic resonance imaging and computed tomography. Physiol. Genomics 2006, 24:154-162.
28. Nimchinsky E.A., Oberlander A.M., Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 2001, 21:5139-5146.
29. O'Donnell W.T., Warren S.T. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 2002, 25:315-338.
30. Oostra B.A., Hoogeveen A.T. Animal model for fragile X syndrome. Ann. Med. 1997, 29:563-567.
31. Pacey L.K., Doering L.C. Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome. Glia 2007, 55:1601-1609.
32. Pacey L.K., Heximer S.P., Hampson D.R. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol. Pharmacol. 2009, 76:18-24.
33. Paradee W., Melikian H.E., Rasmussen D.L., Kenneson A., Conn P.J., Warren S.T. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 1999, 94:185-192.
34. Reiss A.L., Patel S., Kumar A.J., Freund L. Preliminary communication: neuroanatomical variations of the posterior fossa in men with the fragile X (Martin-Bell) syndrome. Am. J. Med. Genet. 1988, 31:407-414.
35. Reiss A.L., Freund L., Tseng J.E., Joshi P.K. Neuroanatomy in fragile X females: the posterior fossa. Am. J. Hum. Genet. 1991, 49:279-288.
36. Reiss A.L., Lee J., Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 1994, 44:1317-1324.
37. Reiss A.L., Abrams M.T., Greenlaw R., Freund L., Denckla M.B. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat. Med. 1995, 1:159-167.
38. Sacchetti B., Scelfo B., Strata P. The cerebellum: synaptic changes and fear conditioning. Neuroscientist 2005, 11:217-227.
39. Spring S., Lerch J.P., Henkelman R.M. Sexual dimorphism revealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging. Neuroimage 2007, 35:1424-1433.
40. Stanfield A.C., McIntosh A.M., Spencer M.D., Philip R., Gaur S., Lawrie S.M. Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur. Psychiatry 2008, 23:289-299.
41. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
42. Thompson R.F., Steinmetz J.E. The role of the cerebellum in classical conditioning of discrete behavioral responses. Neuroscience 2009, 162:732-755.
43. Tucker B., Richards R.I., Lardelli M. Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. Hum. Mol. Genet. 2006, 15:3446-3458.
44. Visootsak J., Warren S.T., Anido A., Graham J.M. Fragile X syndrome: an update and review for the primary pediatrician. Clin. Pediatr. (Phila) 2005, 44:371-381.
45. Yamada J., Noda H. Afferent and efferent connections of the oculomotor cerebellar vermis in the macaque monkey. J. Comp. Neurol. 1987, 265:224-241.
46. Zijdenbos A.P., Forghani R., Evans A.C. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans. Med. Imaging 2002, 21:1280-1291.